Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Patient Participation | 58 | 2024 | 1444 | 7.900 |
Why?
|
Decision Making | 73 | 2024 | 3929 | 6.960 |
Why?
|
Decision Support Techniques | 45 | 2024 | 1998 | 5.660 |
Why?
|
Osteoarthritis, Hip | 9 | 2022 | 409 | 3.280 |
Why?
|
Health Knowledge, Attitudes, Practice | 27 | 2024 | 4016 | 2.350 |
Why?
|
Patient Education as Topic | 22 | 2024 | 2319 | 2.180 |
Why?
|
Osteoarthritis, Knee | 9 | 2022 | 1234 | 2.150 |
Why?
|
Physician-Patient Relations | 14 | 2024 | 3249 | 1.830 |
Why?
|
Patient Preference | 16 | 2024 | 924 | 1.760 |
Why?
|
Mastectomy | 16 | 2022 | 1822 | 1.730 |
Why?
|
Breast Neoplasms | 43 | 2024 | 21012 | 1.700 |
Why?
|
Patient Satisfaction | 16 | 2024 | 3461 | 1.670 |
Why?
|
Psychometrics | 13 | 2021 | 3065 | 1.630 |
Why?
|
Patient-Centered Care | 11 | 2021 | 1421 | 1.520 |
Why?
|
Spinal Stenosis | 5 | 2020 | 261 | 1.330 |
Why?
|
Colorectal Neoplasms | 8 | 2024 | 6935 | 1.270 |
Why?
|
Arthroplasty, Replacement, Hip | 4 | 2022 | 1413 | 1.080 |
Why?
|
Early Detection of Cancer | 15 | 2024 | 3201 | 1.080 |
Why?
|
Arthroplasty, Replacement, Knee | 4 | 2022 | 1393 | 1.070 |
Why?
|
Communication | 11 | 2024 | 3873 | 0.930 |
Why?
|
Informed Consent | 7 | 2019 | 1008 | 0.830 |
Why?
|
Orthopedic Procedures | 2 | 2021 | 1265 | 0.740 |
Why?
|
Genetic Counseling | 2 | 2024 | 627 | 0.730 |
Why?
|
Tracheostomy | 1 | 2024 | 426 | 0.710 |
Why?
|
Quality Assurance, Health Care | 4 | 2016 | 2169 | 0.710 |
Why?
|
Mammaplasty | 5 | 2022 | 1239 | 0.700 |
Why?
|
Knowledge | 1 | 2021 | 177 | 0.680 |
Why?
|
Orthopedics | 2 | 2018 | 898 | 0.650 |
Why?
|
Choice Behavior | 9 | 2024 | 824 | 0.640 |
Why?
|
Caregivers | 4 | 2024 | 2237 | 0.600 |
Why?
|
Reproducibility of Results | 17 | 2023 | 20098 | 0.590 |
Why?
|
Goals | 4 | 2011 | 711 | 0.590 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2023 | 3708 | 0.580 |
Why?
|
Humans | 138 | 2024 | 761504 | 0.570 |
Why?
|
Cross-Sectional Studies | 25 | 2024 | 26125 | 0.570 |
Why?
|
Referral and Consultation | 6 | 2021 | 3600 | 0.510 |
Why?
|
Quality of Health Care | 10 | 2018 | 4330 | 0.510 |
Why?
|
Female | 86 | 2024 | 392644 | 0.490 |
Why?
|
Middle Aged | 57 | 2024 | 220895 | 0.460 |
Why?
|
Aged | 44 | 2024 | 169289 | 0.460 |
Why?
|
Health Care Surveys | 6 | 2017 | 2426 | 0.460 |
Why?
|
Patients | 3 | 2016 | 907 | 0.450 |
Why?
|
Checklist | 2 | 2018 | 827 | 0.450 |
Why?
|
Physicians | 5 | 2023 | 4591 | 0.440 |
Why?
|
Quality Indicators, Health Care | 2 | 2021 | 1792 | 0.440 |
Why?
|
Depression | 3 | 2022 | 8124 | 0.410 |
Why?
|
Coronary Angiography | 3 | 2018 | 4471 | 0.410 |
Why?
|
Lumbar Vertebrae | 4 | 2018 | 1879 | 0.410 |
Why?
|
Quality Improvement | 2 | 2017 | 3801 | 0.400 |
Why?
|
Genetic Testing | 3 | 2024 | 3537 | 0.400 |
Why?
|
Directive Counseling | 2 | 2015 | 170 | 0.400 |
Why?
|
Health Services Research | 3 | 2015 | 1812 | 0.390 |
Why?
|
Quality of Life | 12 | 2022 | 13367 | 0.370 |
Why?
|
Attitude of Health Personnel | 5 | 2017 | 3889 | 0.360 |
Why?
|
Diskectomy | 1 | 2012 | 209 | 0.360 |
Why?
|
Professional-Patient Relations | 2 | 2008 | 726 | 0.360 |
Why?
|
Radial Artery | 1 | 2012 | 187 | 0.360 |
Why?
|
Emotions | 3 | 2020 | 2739 | 0.350 |
Why?
|
Focus Groups | 4 | 2024 | 1413 | 0.350 |
Why?
|
Survivors | 3 | 2012 | 2371 | 0.340 |
Why?
|
Arthroplasty, Replacement | 1 | 2013 | 310 | 0.340 |
Why?
|
Mastectomy, Segmental | 4 | 2017 | 955 | 0.340 |
Why?
|
Catheterization, Peripheral | 1 | 2012 | 343 | 0.310 |
Why?
|
Internal Medicine | 1 | 2016 | 1051 | 0.310 |
Why?
|
Angina Pectoris | 1 | 2012 | 959 | 0.300 |
Why?
|
Male | 43 | 2024 | 360804 | 0.300 |
Why?
|
Femoral Artery | 1 | 2012 | 826 | 0.300 |
Why?
|
Emergency Medicine | 1 | 2016 | 1198 | 0.290 |
Why?
|
Physicians, Primary Care | 2 | 2024 | 623 | 0.290 |
Why?
|
Advance Directives | 1 | 2009 | 249 | 0.290 |
Why?
|
Health Literacy | 3 | 2024 | 444 | 0.280 |
Why?
|
Estrogen Replacement Therapy | 1 | 2014 | 1208 | 0.280 |
Why?
|
Ovarian Neoplasms | 1 | 2024 | 4876 | 0.280 |
Why?
|
Adult | 40 | 2024 | 221177 | 0.280 |
Why?
|
Multicenter Studies as Topic | 2 | 2024 | 1702 | 0.280 |
Why?
|
Pilot Projects | 9 | 2024 | 8631 | 0.280 |
Why?
|
Cooperative Behavior | 3 | 2016 | 1505 | 0.280 |
Why?
|
Primary Health Care | 5 | 2024 | 4686 | 0.270 |
Why?
|
Menopause | 1 | 2014 | 1646 | 0.250 |
Why?
|
Colonoscopy | 2 | 2024 | 1394 | 0.250 |
Why?
|
Perception | 4 | 2024 | 1197 | 0.250 |
Why?
|
Data Collection | 4 | 2023 | 3322 | 0.240 |
Why?
|
Emergency Service, Hospital | 2 | 2016 | 7879 | 0.240 |
Why?
|
Socioeconomic Factors | 6 | 2018 | 7827 | 0.240 |
Why?
|
Time Factors | 4 | 2024 | 39967 | 0.230 |
Why?
|
Maine | 1 | 2024 | 147 | 0.230 |
Why?
|
Comparative Effectiveness Research | 2 | 2019 | 709 | 0.230 |
Why?
|
Qualitative Research | 3 | 2024 | 3023 | 0.220 |
Why?
|
Patient Acceptance of Health Care | 2 | 2021 | 3205 | 0.220 |
Why?
|
Aged, 80 and over | 11 | 2024 | 58976 | 0.220 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 2373 | 0.220 |
Why?
|
Neoplasms | 6 | 2023 | 22170 | 0.210 |
Why?
|
Cardiology | 1 | 2014 | 1656 | 0.210 |
Why?
|
Decision Theory | 2 | 2015 | 27 | 0.210 |
Why?
|
Academic Medical Centers | 4 | 2023 | 2759 | 0.200 |
Why?
|
Mass Screening | 5 | 2024 | 5428 | 0.200 |
Why?
|
Massachusetts | 4 | 2024 | 8830 | 0.200 |
Why?
|
Pamphlets | 2 | 2014 | 71 | 0.200 |
Why?
|
Information Dissemination | 1 | 2011 | 1126 | 0.200 |
Why?
|
Curriculum | 1 | 2016 | 3743 | 0.200 |
Why?
|
Delivery of Health Care | 3 | 2023 | 5336 | 0.200 |
Why?
|
Video Recording | 2 | 2019 | 966 | 0.190 |
Why?
|
Delphi Technique | 3 | 2018 | 846 | 0.190 |
Why?
|
Neoplasm Metastasis | 2 | 2009 | 4915 | 0.190 |
Why?
|
United States | 17 | 2024 | 72334 | 0.190 |
Why?
|
Occult Blood | 1 | 2022 | 198 | 0.190 |
Why?
|
Program Development | 3 | 2016 | 1297 | 0.190 |
Why?
|
Research Design | 2 | 2015 | 6180 | 0.190 |
Why?
|
Surgical Procedures, Operative | 1 | 2013 | 1922 | 0.190 |
Why?
|
Algorithms | 2 | 2020 | 14031 | 0.190 |
Why?
|
Chemotherapy, Adjuvant | 7 | 2022 | 3514 | 0.190 |
Why?
|
Reminder Systems | 1 | 2024 | 388 | 0.190 |
Why?
|
Pediatrics | 1 | 2016 | 3589 | 0.180 |
Why?
|
Osteoarthritis | 2 | 2018 | 1063 | 0.170 |
Why?
|
Clinical Competence | 1 | 2016 | 4792 | 0.170 |
Why?
|
Chemoprevention | 1 | 2002 | 326 | 0.170 |
Why?
|
Anxiety | 4 | 2024 | 4573 | 0.170 |
Why?
|
Interviews as Topic | 4 | 2024 | 2696 | 0.170 |
Why?
|
Independent Living | 1 | 2024 | 579 | 0.170 |
Why?
|
Intention | 1 | 2022 | 347 | 0.170 |
Why?
|
Disclosure | 2 | 2024 | 748 | 0.160 |
Why?
|
Acute Coronary Syndrome | 1 | 2012 | 2190 | 0.160 |
Why?
|
Feasibility Studies | 4 | 2012 | 5247 | 0.160 |
Why?
|
California | 2 | 2014 | 1429 | 0.160 |
Why?
|
Electronics | 1 | 2020 | 318 | 0.160 |
Why?
|
Esthetics | 2 | 2010 | 330 | 0.150 |
Why?
|
Social Support | 2 | 2024 | 2171 | 0.150 |
Why?
|
Videotape Recording | 2 | 2011 | 337 | 0.150 |
Why?
|
Home Care Services | 1 | 2024 | 648 | 0.150 |
Why?
|
Prospective Studies | 9 | 2024 | 54425 | 0.150 |
Why?
|
Opioid-Related Disorders | 2 | 2024 | 2164 | 0.150 |
Why?
|
Patient Care Planning | 1 | 2002 | 908 | 0.140 |
Why?
|
Longitudinal Studies | 4 | 2021 | 14605 | 0.140 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 3245 | 0.130 |
Why?
|
Health Policy | 2 | 2011 | 2684 | 0.130 |
Why?
|
Utilization Review | 1 | 2017 | 382 | 0.130 |
Why?
|
Confidence Intervals | 3 | 2010 | 2927 | 0.130 |
Why?
|
Trust | 1 | 2020 | 530 | 0.130 |
Why?
|
Hip Fractures | 1 | 2024 | 988 | 0.130 |
Why?
|
Consumer Health Information | 1 | 2018 | 215 | 0.130 |
Why?
|
Patient Care Team | 2 | 2017 | 2521 | 0.130 |
Why?
|
Program Evaluation | 2 | 2016 | 2495 | 0.120 |
Why?
|
Expert Testimony | 1 | 2017 | 364 | 0.120 |
Why?
|
Primary Prevention | 1 | 2002 | 1186 | 0.120 |
Why?
|
Aortic Valve Insufficiency | 1 | 2019 | 576 | 0.120 |
Why?
|
Leiomyoma | 2 | 2009 | 636 | 0.120 |
Why?
|
Body Image | 1 | 2019 | 638 | 0.120 |
Why?
|
Cardiovascular Diseases | 3 | 2022 | 15500 | 0.120 |
Why?
|
Educational Status | 3 | 2010 | 2522 | 0.120 |
Why?
|
Politics | 1 | 2021 | 815 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2019 | 10209 | 0.110 |
Why?
|
Evaluation Studies as Topic | 1 | 2016 | 1624 | 0.110 |
Why?
|
Spinal Diseases | 1 | 2018 | 564 | 0.110 |
Why?
|
Educational Measurement | 3 | 2010 | 1254 | 0.110 |
Why?
|
Research Subjects | 1 | 2015 | 249 | 0.110 |
Why?
|
Fear | 2 | 2019 | 1476 | 0.110 |
Why?
|
Sweating | 1 | 2014 | 155 | 0.110 |
Why?
|
Workflow | 1 | 2017 | 851 | 0.100 |
Why?
|
Social Class | 2 | 2020 | 2004 | 0.100 |
Why?
|
Pandemics | 2 | 2022 | 8654 | 0.100 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2024 | 2020 | 0.100 |
Why?
|
Risk Assessment | 9 | 2024 | 23995 | 0.100 |
Why?
|
Costs and Cost Analysis | 1 | 2018 | 1668 | 0.100 |
Why?
|
Down Syndrome | 1 | 2020 | 901 | 0.100 |
Why?
|
Child | 4 | 2024 | 80153 | 0.100 |
Why?
|
Colonic Neoplasms | 1 | 2023 | 2538 | 0.100 |
Why?
|
Hospitals, General | 1 | 2016 | 798 | 0.100 |
Why?
|
Prostatic Neoplasms | 3 | 2024 | 11118 | 0.100 |
Why?
|
Patient Discharge | 1 | 2024 | 3443 | 0.090 |
Why?
|
Medicare | 2 | 2024 | 6770 | 0.090 |
Why?
|
Defibrillators, Implantable | 1 | 2021 | 1490 | 0.090 |
Why?
|
Health Personnel | 4 | 2023 | 3335 | 0.090 |
Why?
|
San Francisco | 1 | 2011 | 162 | 0.090 |
Why?
|
Hot Flashes | 1 | 2014 | 330 | 0.090 |
Why?
|
Retrospective Studies | 7 | 2024 | 80636 | 0.090 |
Why?
|
Neoplasm Staging | 4 | 2018 | 11121 | 0.090 |
Why?
|
Health Status | 2 | 2021 | 4077 | 0.090 |
Why?
|
Cohort Studies | 4 | 2019 | 41487 | 0.090 |
Why?
|
Observation | 1 | 2012 | 310 | 0.090 |
Why?
|
Random Allocation | 1 | 2014 | 2395 | 0.090 |
Why?
|
Social Values | 2 | 2011 | 225 | 0.080 |
Why?
|
Peripheral Arterial Disease | 1 | 2021 | 1273 | 0.080 |
Why?
|
Dementia | 1 | 2024 | 2686 | 0.080 |
Why?
|
Diagnostic Self Evaluation | 1 | 2011 | 224 | 0.080 |
Why?
|
Heart Valve Diseases | 1 | 2017 | 1027 | 0.080 |
Why?
|
Practice Guidelines as Topic | 4 | 2018 | 7390 | 0.080 |
Why?
|
Stress, Psychological | 1 | 2024 | 4481 | 0.080 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2019 | 1553 | 0.080 |
Why?
|
Mammography | 1 | 2019 | 2430 | 0.080 |
Why?
|
Insurance Claim Review | 1 | 2013 | 741 | 0.080 |
Why?
|
Health Plan Implementation | 1 | 2011 | 337 | 0.080 |
Why?
|
Attitude to Health | 1 | 2017 | 2025 | 0.080 |
Why?
|
Logistic Models | 3 | 2011 | 13255 | 0.070 |
Why?
|
Neurosurgical Procedures | 1 | 2018 | 2072 | 0.070 |
Why?
|
Lung Neoplasms | 2 | 2021 | 13380 | 0.070 |
Why?
|
Aortic Valve Stenosis | 1 | 2019 | 2001 | 0.070 |
Why?
|
Tumor Burden | 3 | 2017 | 1893 | 0.070 |
Why?
|
Education | 1 | 2008 | 537 | 0.060 |
Why?
|
Cognition | 1 | 2023 | 6990 | 0.060 |
Why?
|
Internationality | 1 | 2011 | 1001 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 11742 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2015 | 2047 | 0.060 |
Why?
|
Tape Recording | 1 | 2024 | 77 | 0.060 |
Why?
|
Internal-External Control | 1 | 2006 | 358 | 0.060 |
Why?
|
Prostatic Hyperplasia | 1 | 2008 | 521 | 0.060 |
Why?
|
Treatment Outcome | 7 | 2024 | 64680 | 0.060 |
Why?
|
Internet | 3 | 2017 | 3092 | 0.060 |
Why?
|
Uncertainty | 2 | 2024 | 754 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3416 | 0.060 |
Why?
|
Quality Control | 1 | 2006 | 832 | 0.060 |
Why?
|
Coronary Artery Bypass | 1 | 2013 | 2188 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 9280 | 0.060 |
Why?
|
Control Groups | 1 | 2023 | 104 | 0.050 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2017 | 857 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2013 | 2691 | 0.050 |
Why?
|
Community Health Centers | 1 | 2006 | 461 | 0.050 |
Why?
|
Community Health Services | 1 | 2008 | 656 | 0.050 |
Why?
|
Germany | 1 | 2024 | 875 | 0.050 |
Why?
|
Needs Assessment | 1 | 2008 | 1139 | 0.050 |
Why?
|
Denmark | 1 | 2024 | 771 | 0.050 |
Why?
|
Lung | 1 | 2021 | 10000 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3358 | 0.050 |
Why?
|
Health Surveys | 1 | 2012 | 4061 | 0.050 |
Why?
|
Health Care Reform | 1 | 2011 | 1247 | 0.050 |
Why?
|
Child, Preschool | 1 | 2024 | 42230 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2023 | 17904 | 0.050 |
Why?
|
Sweden | 1 | 2024 | 1379 | 0.050 |
Why?
|
Odds Ratio | 2 | 2010 | 9646 | 0.050 |
Why?
|
Comprehension | 1 | 2006 | 621 | 0.050 |
Why?
|
Genes, BRCA2 | 2 | 2015 | 601 | 0.050 |
Why?
|
Australia | 1 | 2024 | 1250 | 0.050 |
Why?
|
Bariatric Surgery | 1 | 2011 | 992 | 0.050 |
Why?
|
Appointments and Schedules | 1 | 2024 | 443 | 0.040 |
Why?
|
Genes, BRCA1 | 2 | 2015 | 764 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2017 | 4811 | 0.040 |
Why?
|
Multivariate Analysis | 2 | 2010 | 12059 | 0.040 |
Why?
|
Risk Factors | 6 | 2022 | 74206 | 0.040 |
Why?
|
Netherlands | 1 | 2024 | 2221 | 0.040 |
Why?
|
Certification | 2 | 2017 | 418 | 0.040 |
Why?
|
Depressive Disorder, Major | 1 | 2017 | 4761 | 0.040 |
Why?
|
Canada | 1 | 2024 | 2122 | 0.040 |
Why?
|
Communication Barriers | 1 | 2002 | 413 | 0.040 |
Why?
|
Reproduction | 1 | 2023 | 645 | 0.040 |
Why?
|
Intermittent Claudication | 1 | 2021 | 304 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2018 | 6403 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39106 | 0.040 |
Why?
|
Terminal Care | 1 | 2009 | 1760 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 1036 | 0.040 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2004 | 926 | 0.030 |
Why?
|
Benchmarking | 1 | 2003 | 1045 | 0.030 |
Why?
|
Personal Satisfaction | 1 | 2020 | 644 | 0.030 |
Why?
|
Internship and Residency | 1 | 2016 | 5880 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1750 | 0.030 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2003 | 1085 | 0.030 |
Why?
|
Social Stigma | 1 | 2021 | 769 | 0.030 |
Why?
|
General Surgery | 2 | 2010 | 1692 | 0.030 |
Why?
|
Risk | 2 | 2021 | 9610 | 0.030 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2022 | 1520 | 0.030 |
Why?
|
Lymphatic Metastasis | 2 | 2015 | 2915 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2000 | 2850 | 0.030 |
Why?
|
Models, Statistical | 1 | 2008 | 5079 | 0.030 |
Why?
|
Neoadjuvant Therapy | 1 | 2004 | 2827 | 0.030 |
Why?
|
Models, Biological | 1 | 2008 | 9469 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2018 | 1440 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2019 | 2115 | 0.020 |
Why?
|
Parity | 1 | 2015 | 927 | 0.020 |
Why?
|
Reference Values | 1 | 2019 | 4920 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2002 | 2629 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2017 | 2218 | 0.020 |
Why?
|
Placebos | 1 | 2015 | 1667 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2022 | 8529 | 0.020 |
Why?
|
Heart Valve Prosthesis | 1 | 2019 | 1462 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2022 | 3466 | 0.020 |
Why?
|
Doxorubicin | 1 | 2017 | 2224 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2002 | 3688 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3384 | 0.020 |
Why?
|
Forecasting | 2 | 2011 | 2928 | 0.020 |
Why?
|
Paclitaxel | 1 | 2017 | 1732 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2018 | 1175 | 0.020 |
Why?
|
Medical Oncology | 1 | 2000 | 2321 | 0.020 |
Why?
|
Health Behavior | 1 | 2019 | 2643 | 0.020 |
Why?
|
Psychotherapy | 1 | 2017 | 1647 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2010 | 15631 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10552 | 0.020 |
Why?
|
Self Efficacy | 1 | 2011 | 638 | 0.020 |
Why?
|
Pain | 1 | 2022 | 5073 | 0.020 |
Why?
|
Prognosis | 2 | 2008 | 29625 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10090 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2017 | 2897 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2015 | 2557 | 0.010 |
Why?
|
Age Factors | 1 | 2021 | 18395 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2018 | 3530 | 0.010 |
Why?
|
Prescription Drugs | 1 | 2010 | 631 | 0.010 |
Why?
|
Survival Rate | 1 | 2017 | 12725 | 0.010 |
Why?
|
Recurrence | 1 | 2015 | 8465 | 0.010 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2004 | 361 | 0.010 |
Why?
|
Infant | 1 | 2024 | 36192 | 0.010 |
Why?
|
Young Adult | 2 | 2021 | 59243 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29874 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2008 | 14666 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2015 | 12341 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2008 | 2208 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 88319 | 0.010 |
Why?
|
Mutation | 2 | 2015 | 30052 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2004 | 1784 | 0.010 |
Why?
|
Research | 1 | 2006 | 1982 | 0.010 |
Why?
|
Body Mass Index | 1 | 2015 | 12953 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2007 | 3575 | 0.010 |
Why?
|
Software | 1 | 2008 | 4434 | 0.010 |
Why?
|
Comorbidity | 1 | 2008 | 10508 | 0.010 |
Why?
|
Disease Progression | 1 | 2004 | 13506 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2004 | 36426 | 0.000 |
Why?
|